Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial
暂无分享,去创建一个
Chengcheng Guo | Wenyu Li | H. Hong | Hong-qiang Guo | D. Xie | S. Ye | Zhao Wang | X. Fang | He Huang | Xueying Li | Yabing Cao | Su-xia Lin | Yong Zhou | X. Pu | Yingcheng Lin | Qing Liu | Bing Xu | Wei Wang | Xiangyuan Wu | Jiewen Peng | T. Lin | J. Yi | Hongyu Zhan | Xiang-yuan Wu